- All Articles
- Biologics Zone
- Blood Management
- Circuit Surfers
- ECMO Zone
- Education Zone
- HIPEC Zone
- i-Pump Quick Reference
- Main Zone
- Mobile Zone
- Multimedia Zone
- Pediatric Zone
- Perfusion Devices
- Perfusion Zone
- Premium Zone
- Tiny Perfusion Letter
- Warnings and Recalls
Structured Review of Post-cardiotomy Extracorporeal Membrane Oxygenation: Part 2—Pediatric Patients
This report, aims to present a comprehensive overview of the available literature informing patient selection, ECMO management, and in-hospital and early post-discharge outcomes in pediatric patients treated with ECMO for post-cardiotomy cardiorespiratory failure.
Structured Review of Post-cardiotomy Extracorporeal Membrane Oxygenation: Part 1—Adult Patients
This report, aims to present a comprehensive overview of the literature with respect to the prevalence of ECMO use, patient characteristics, ECMO management, and in-hospital and early post-discharge patient outcomes for those treated for post-cardiotomy heart, lung, or heart-lung failure.
Extracorporeal Life Support in Myocardial Infarction-Induced Cardiogenic Shock: Weaning Success
Emergency ECLS is a valuable option among patients with AMI-induced CS with low and intermediate IABP-SHOCK II risk scores.
Microcirculation Evolution in Patients on Venoarterial Extracorporeal Membrane Oxygenation for Refractory Cardiogenic Shock
Microcirculation is severely impaired in patients with refractory cardiogenic shock requiring venoarterial extracorporeal membrane oxygenation.
Early and Long-Term Outcomes Comparing Neonates, Infants, and Preadolescents Requiring Extracorporeal Membrane Oxygenation for Heart Failure
Veno-arterial extracorporeal membrane oxygenation is a lifesaving therapeutic chance for pediatric patients in the setting of either failure to wean from cardiopulmonary bypass or failed resuscitation from cardiac arrest.
A Novel Adaptor System Enables Endovascular Access Through Extracorporeal Life Support Circuits
Extracorporeal life support has traditionally been used as a supportive platform for patients with cardiopulmonary failure.
High Hemoglobin Level As a Limiting Factor for Extracorporeal Membrane Oxygenation
We report the case of a 47 year old male who developed acute respiratory distress syndrome after bariatric surgery, requiring a venovenous extracorporeal membrane oxygenation.
Impact of Age on Outcomes of Patients Assisted by Veno-arterial or Veno-venous Extra-corporeal Membrane Oxygenation: 403 Patients Between 2005 and 2015
Patients older than 65 years have higher mortality after veno-arterial extra-corporeal membrane oxygenation or veno-venous extra-corporeal membrane oxygenation.
Acquired von Willebrand Syndrome in Pediatric Extracorporeal Membrane Oxygenation Patients: A Single Institution’s Experience
Describe the prevalence of acquired von Willebrand syndrome in pediatric patients undergoing extracorporeal membrane oxygenation deemed to be at increased risk for the disease in our institution.
Anti-Factor Xa–Based Anticoagulation during Extracorporeal Membrane Oxygenation: Potential Problems and Possible Solutions
Choices for monitoring of unfractionated heparin (UFH) anticoagulation in extracorporeal membrane oxygenation (ECMO) patients include activated clotting time, activated partial thromboplastin time, reaction times of viscoelastic tests, and anti-factor Xa activity.
How I Wean Patients From Veno-venous Extra-corporeal Membrane Oxygenation
Identifying patients who are ready for weaning and liberation from veno-venous extracorporeal membrane oxygenation (ECMO) is challenging in clinical practice.
Ultra-high Pre-membrane Lung Oxygen Saturation in a Patient on Veno-arterial Extracorporeal Membrane Oxygenation
A 55-year-old man who suffered from acute myocardial infarction complicated with cardiogenic shock was administered veno-arterial extracorporeal membrane oxygenation.
High-efficiency, High-flux In-line Hemofiltration Using a High Blood Flow Extracorporeal Circuit
The ability of current renal replacement therapy modalities to achieve rapid solute removal is limited by membrane surface area and blood flow rate.
Extracorporeal Membrane Oxygenation in Life-threatening Massive Pulmonary Embolism
In massive pulmonary embolism (PE) with circulatory collapse or with cardiac arrest, treatment can be difficult.
Establishing an ECMO Program in a Developing Country: Challenges and Lessons Learned
The ECMO (extracorporeal membrane oxygenation) Program at the American University of Beirut Medical Center was established in November 2015 as the first program serving adult and pediatric population in a low-resource setting.
Accumulations of von Willebrand Factor Within ECMO Oxygenators: Potential Indicator of Coagulation Abnormalities in Critically Ill Patients?
Clot formation within membrane oxygenators (MOs) remains a critical problem during extracorporeal membrane oxygenation (ECMO).
Heparin-Free Extracorporeal Life Support Using Tethered Liquid Perfluorocarbon: A Feasibility and Efficacy Study
Coagulation management is the leading challenge during extracorporeal life support (ECLS) due to shear stress and foreign-surface–induced coagulation disturbance during circulation.
Impact of Age of Packed RBC Transfusion on Oxygenation in Patients Receiving Extracorporeal Membrane Oxygenation
To determine the effect of age of packed RBCs on tissue oxygenation in children receiving extracorporeal membrane oxygenation support.
Extracorporeal Membrane Oxygenation: Indications, Technique and Contemporary Outcomes
Extracorporeal membrane oxygenation (ECMO) is an advanced form of temporary life support, to aid respiratory and/or cardiac function. It has been used since the early 1970s and is based on cardiopulmonary bypass technology and diverts venous blood through an extracorporeal circuit and returns it to the body after gas exchange through a semi-permeable membrane.
Neurologic Outcomes in Patients Who Undergo Extracorporeal Cardiopulmonary Resuscitation
This study aimed to develop a risk prediction model for neurologic outcomes in patients who underwent extracorporeal cardiopulmonary resuscitation (ECPR).
Left Ventricular Decompression on Veno-arterial Extracorporeal Membrane Oxygenation With Intra-aortic Balloon Counterpulsation
There has been growing recognition of the favorable and unfavorable hemodynamic effects of this therapy and recent interest in the use of other percutaneous circulatory support devices to offset some of the potentially harmful hemodynamic effects.
Structured Review of Post-cardiotomy Extracorporeal Membrane Oxygenation: Part 2 – Pediatric Patients
Veno-arterial extracorporeal membrane oxygenation (ECMO) is established therapy for short-term circulatory support for children with life-treating cardiorespiratory dysfunction.
Discriminatory Power of Scoring Systems for Outcome Prediction in Patients With Extracorporeal Membrane Oxygenation Following Cardiovascular Surgery
Although extracorporeal membrane oxygenation (ECMO) represents a rapidly evolving treatment option in patients with refractory heart or lung failure, survival remains poor and appropriate risk stratification challenging because established risk prediction models have not been validated for this specific population.
Dexmedetomidine Extraction by the Extracorporeal Membrane Oxygenation Circuit: Results From an in Vitro Study
Dexmedetomidine is a sedative administered to minimize distress and decrease the risk of life threatening complications in children supported with extracorporeal membrane oxygenation. The extracorporeal membrane oxygenation circuit can extract drug and decrease drug exposure, placing the patient at risk of therapeutic failure.